Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Chattanooga
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Chattanooga, TN

Studies commonly pay $75 to $4,500 per completed study

142 clinical trials are currently recruiting participants within 30 miles of Chattanooga. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

142studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Chattanooga right now

Top 25 of 142 recruiting studies, sorted by proximity — each links to its official registry page

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1, Phase 2 Interventional 754 participants sought
Tennessee Oncology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05379985)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
Chattanooga Medical Research /ID# 257631 — Chattanooga, Tennessee (3.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06345339)

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Breast Cancer, Triple Negative Breast Cancer Phase 2 Interventional 110 participants sought
Sarah Cannon Research Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Dana-Farber Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT04468061)

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital Phase 3 Interventional 400 participants sought
Chattanooga Medical Research, Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: pH-D Feminine Health LLC
See eligibility & contact on ClinicalTrials.gov (NCT07109869)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Galen Medical Group - Galen Hepatology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07165028)

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia Phase 2 Interventional 186 participants sought
University Diabetes & Endocrine Consultants — Chattanooga, Tennessee (3.8 mi) · Sponsor: Zucara Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05762107)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Southeastern Retina Associates — Hixson, Tennessee (5.2 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT05844982)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Chattanooga Heart Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Uterine Fibroids, Endometriosis Phase 3 Interventional 1,000 participants sought
Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Sumitomo Pharma Switzerland GmbH
See eligibility & contact on ClinicalTrials.gov (NCT05862272)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
Tennessee Oncology - Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06246916)

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

COPD (Chronic Obstructive Pulmonary Disease) Phase 3 Interventional 5,000 participants sought
Research Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06283966)

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 600 participants sought
Site 60 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merus B.V.
See eligibility & contact on ClinicalTrials.gov (NCT06496178)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 Diabetes Mellitus, T1D Phase 1, Phase 2 Interventional 72 participants sought
University Diabetes & Endocrine Consultants — Chattanooga, Tennessee (3.8 mi) · Sponsor: COUR Pharmaceutical Development Company, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06783309)

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought
Tennessee Oncology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 500 participants sought
Local Institution - 0268 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07100080)

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostatic Neoplasms Phase 3 Interventional 1,203 participants sought
Tennessee Oncology - Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07164443)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Tennessee Oncology-Chattanooga ( Site 0045) — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD) Phase 2 Interventional 195 participants sought
Southeast Renal Research Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07271186)

An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.

Hypothyroidism Phase 3 Interventional 466 participants sought
M3 Wake Research — Chattanooga, Tennessee (3.8 mi) · Sponsor: Neuvosyn Laboratories, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07747103)

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Agitation, Alzheimer Disease Phase 2 Interventional 120 participants sought
Local Institution - 0031 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Celgene
See eligibility & contact on ClinicalTrials.gov (NCT06808984)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought
T C Thompson Children's Hospital — Chattanooga, Tennessee (3.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02402244)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer Phase 3 Interventional 868 participants sought
Greco-Hainsworth Centers for Research ( Site 4034) — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06077760)

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 700 participants sought
Tennessee Oncology Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06890598)
Actively enrolling

Studies you may be able to join near Chattanooga

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Chattanooga

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

M3 Wake Research Chattanooga

★ 4.5
6035 Shallowford Rd, Chattanooga, TN 37421
(423) 698-4584
"Great friendly staff, get paid for participating in qualified medical research."
— Tyler Yeager, 5★

Nova Research Trials

725 Glenwood Dr Ste 686, Chattanooga, TN 37404
(423) 703-0888

Lynn Institute of Chattanooga

Located in the Missionary Ridge Medical Tower, 725 Glenwood Dr #888, Chattanooga, TN 37404
(423) 713-5966

Chattanooga Research & Medicine

2205 McCallie Ave Ste 301, Chattanooga, TN 37404
(423) 643-2253

Chattanooga Medical Research

★ 5.0
929 Spring Creek Rd, Chattanooga, TN 37412
(423) 648-7794

Wilkins Research Services

★ 4.0
1730 Gunbarrel Rd, Chattanooga, TN 37421
(423) 894-9478
"I had my very first focus group today and I was nervous since I have never done anything like his before. They were extremely sweet, offered us drink…"
— Leila Parker, 5★

Erlanger Endocrinology

★ 2.3
979 E 3rd St Ste A-550, Chattanooga, TN 37403
(423) 778-8224
"Have an appointment today after waiting for 3 months but I haven't been able to get ahold of anyone at the office. They absolutely suck . Please if …"
— sticky mess, 1★

Southeast Clinical Research Center

1102 W Waugh St, Dalton, GA 30720
(706) 913-1779

Scenic City Neurotherapy and Ketamine Center

★ 4.9 (82 reviews)
7405 Shallowford Rd STE 240, Chattanooga, TN 37421
(423) 228-0579
"Exceptional staff across the board. Charles and Brian are incredible providers, Connie, the receptionist is a joy to talk to and be welcomed by every…"
— James Dietzen, 5★

Clinical trials in Chattanooga: what's recruiting

The Chattanooga area currently has 142 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Chattanooga, the most active research areas are:

  • Cancer & Oncology12 studies
  • Diabetes & Metabolism4 studies
  • Liver & Kidney3 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Chattanooga, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Chattanooga

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Chattanooga participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Chattanooga pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Chattanooga?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Chattanooga safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Chattanooga?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Chattanooga

Other metros within reach

Murfreesboro, TN79 Huntsville, AL93 Atlanta, GA1,711 Knoxville, TN235 Gainesville, GA154 Nashville, TN1,331 Birmingham, AL973 Athens, GA75

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Chattanooga Bladder Issues Due To Spinal Cord Injury in Chattanooga All conditions

More of TN

Nashville1,331 Memphis580 Knoxville235 Murfreesboro79 Clarksville8

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts